- mab: Adintrevimab
  synonyms: ADG20;ADG-2
  num_ref_name: 21
  num_fold: 173
  avail: Phase 3
  target: RBD
  class: RBD Core Cluster I
  pdb: 7U2D
  institute: Adagio Therapeutics
  origin: CP
- mab: C144
  synonyms: BMS-986413
  num_ref_name: 12
  num_fold: 144
  avail: Phase 2/3
  target: RBD
  class: RBM Class III
  pdb: 7K90
  institute: Rockefeller University
  origin: CP
- mab: C135
  synonyms: BMS-986414
  num_ref_name: 8
  num_fold: 84
  avail: Phase 2/3
  target: RBD
  class: RBD Core Cluster I
  pdb: 7K8Z
  institute: Rockefeller University
  origin: CP
- mab: DXP-604
  synonyms: BD-604
  num_ref_name: 3
  num_fold: 21
  avail: Phase 1
  target: RBD
  class: RBM Class I
  pdb: 7CH4
  institute: Singlomics Biopharmaceuticals
  origin: CP
- mab: ABBV-47D11
  synonyms: 47D11
  num_ref_name: 2
  num_fold: 11
  avail: Phase 1
  target: RBD
  class: RBD Core Cluster I
  pdb: 7AKD
  institute: Utrecht University & AbbVie
  origin: Transgenic mice
- mab: Regdanvimab
  synonyms: CT-P59
  num_ref_name: 15
  num_fold: 86
  avail: KR-Approved
  target: RBD
  class: RBM Class I
  pdb: 7CM4
  institute: Celltrion
  origin: Phage display library
- mab: Imdevimab
  synonyms: REGN10987
  num_ref_name: 79
  num_fold: 692
  avail: EUA
  target: RBD
  class: RBD Core Cluster I
  pdb: 6XDG
  institute: Regeneron
  origin: Transgenic mice
- mab: Casirivimab
  synonyms: REGN10933
  num_ref_name: 77
  num_fold: 645
  avail: EUA
  target: RBD
  class: RBM Class I
  pdb: 6XDG
  institute: Regeneron
  origin: Transgenic mice
- mab: Sotrovimab
  synonyms: GSK4182136;S309;Vir-7831
  num_ref_name: 61
  num_fold: 608
  avail: EUA
  target: RBD
  class: RBD Core Cluster I
  pdb: 6WPS
  institute: Vir Biotechnol
  origin: SARS-CoV CP
- mab: Etesevimab
  synonyms: CB6;Shi-CB6;JS-016;LY-CoV016;LY3832479
  num_ref_name: 61
  num_fold: 577
  avail: EUA
  target: RBD
  class: RBM Class I
  pdb: 7C01
  institute: Eli Lilly
  origin: CP
- mab: Bamlanivimab
  synonyms: LY-CoV555;LY3819253
  num_ref_name: 57
  num_fold: 447
  avail: EUA
  target: RBD
  class: RBM Class II
  pdb: 7KMG
  institute: Eli Lilly
  origin: CP
- mab: Bebtelovimab
  synonyms: LY-CoV1404;LY3853113
  num_ref_name: 12
  num_fold: 358
  avail: EUA
  target: RBD
  class: RBM Class II
  pdb: 7MMO
  institute: Eli Lilly
  origin: CP
- mab: Cilgavimab
  synonyms: COV2-2130;AZD1061
  num_ref_name: 48
  num_fold: 334
  avail: EUA
  target: RBD
  class: RBM Class II
  pdb: 7L7E
  institute: AstraZeneca
  origin: CP
- mab: Tixagevimab
  synonyms: COV2-2196;AZD8895
  num_ref_name: 48
  num_fold: 325
  avail: EUA
  target: RBD
  class: RBM Class I
  pdb: 7L7E
  institute: AstraZeneca
  origin: CP
- mab: Amubarvimab
  synonyms: BRII-196;P2C-1F11
  num_ref_name: 17
  num_fold: 297
  avail: CN-Approved
  target: RBD
  class: RBM Class I
  pdb: 7CDI
  institute: Brii Biosciences
  origin: ''
- mab: Romlusevimab
  synonyms: BRII-198;P2B-1G5
  num_ref_name: 11
  num_fold: 143
  avail: CN-Approved
  target: RBD
  class: RBD Core Cluster II
  pdb: ''
  institute: Brii Biosciences
  origin: ''
